Advances in liquid biopsy on-chip for cancer management: Technologies, biomarkers, and clinical analysis

References

• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
   Google Scholar
• Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract. 2010;60:121–128.
   PubMed Web of Science ®Google Scholar
• Liu C, Pan C, Shen J, et al. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of colorectal cancer. Int J Med Sci. 2011;8:39–47.
   PubMed Web of Science ®Google Scholar
• Kaur S, Baine MJ, Jain M, et al. Early diagnosis of pancreatic cancer: challenges and new developments. Biomark Med. 2012;6:597–612.
   PubMed Web of Science ®Google Scholar
• Karachaliou N, Mayo-de-las-casas C, Molina-vila MA, et al. Real-time liquid biopsies become a reality in cancer treatment. Ann Transl Med. 2015;3:36.
   Google Scholar
• Soper SA, Brown K, Ellington A, et al. Point-of-care biosensor systems for cancer diagnostics/prognostics. Biosens Bioelectron. 2006;21:1932–1942.
   PubMed Web of Science ®Google Scholar
• Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17:223–238.
   PubMed Web of Science ®Google Scholar
• Cree IA, Deans Z, Ligtenberg MJL, et al. Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol. 2014;67:923–931.
   PubMed Web of Science ®Google Scholar
• Gold B, Cankovic M, Furtado LV, et al. Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility?: a report of the association for molecular pathology. J Mol Diagnostics. 2015;17:209–224.
   PubMed Web of Science ®Google Scholar
• Quandt D, Zucht H, Amann D, et al. Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget. 2017;8:48507–48520.
   Google Scholar
• Tu M, Chia D, Wei F, et al. Liquid biopsy for detection of actionable oncogenic mutations in human cancers and electric field induced release and measurement liquid biopsy (eLB). Analyst. 2016;141:393–402.
   PubMed Web of Science ®Google Scholar
• Perakis S, Speicher MR. Emerging concepts in liquid biopsies. BMC Med. 2017;15:75.
   PubMed Web of Science ®Google Scholar
• Tadimety A, Syed A, Nie Y, et al. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis. Integr Biol (Camb). 2017;9:22–49.
   PubMed Web of Science ®Google Scholar
• Tadimety A, Syed A, Nie Y, et al. Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis. Integr Biol (Camb). 2017;64:9–29.
   Google Scholar
• Nguyen AH, Sim SJ. Nanoplasmonic biosensor: detection and amplification of dual bio-signatures of circulating tumor DNA. Biosens Bioelectron. 2015;67:443–449.
   PubMed Web of Science ®Google Scholar
• Bellassai N, Spoto G. Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer. Anal Bioanal Chem. 2016;408:7255–7264.
   PubMed Web of Science ®Google Scholar
• Mayer KM, Hafner JH, Antigen AÀ. Localized surface plasmon resonance sensors. Chem Rev. 2011;111:3828–3857.
   Google Scholar
• Stewart ME, Anderton CR, Thompson LB, et al. Nanostructured plasmonic sensors. Chem Rev. 2008;108:494–521.
   PubMed Web of Science ®Google Scholar
• Song Y, Huang YY, Liu X, et al. Point-of-care technologies for molecular diagnostics using a drop of blood. Trends Biotechnol. 2014;32:132–139.
   PubMed Web of Science ®Google Scholar
• Capaldo P, Alfarano SR, Ianeselli L, et al. Circulating disease biomarker detection in complex matrices: real-time, in situ measurements of DNA/miRNA hybridization via electrochemical impedance spectroscopy. ACS Sens. 2016;1:1003–1010.
   Web of Science ®Google Scholar
• Jia S, Zhang S, Li RZ, et al. Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer. Oncotarget. 2017;8:55632–55645.
   PubMedGoogle Scholar
• Zhang W, Xia W, Lv Z, et al. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes? Cell Physiol Biochem. 2017;41:755–768.
   PubMed Web of Science ®Google Scholar
• Hao N, Zhang JXJ. Microfluidic screening of circulating tumor biomarkers toward liquid biopsy. Sep Purif Rev. 2017;47:19–48.
   Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674.
   PubMed Web of Science ®Google Scholar
• Man Y, Wang Q, Kemmner W. Currently used markers for CTC isolation - advantages, limitations and impact on cancer prognosis. J Clinic Experiment Pathol. 2011;1:1–7.
   Google Scholar
• Ferreira MM, Ramani VC, Jeffrey SS. Circulating tumor cell technologies. Mol Oncol. 2016;10:1–21.
   PubMedGoogle Scholar
• Hendrix A, Hume A. Exosome signaling in mammary gland development and cancer. Int J Dev Biol. 2011;55:879–887.
   PubMed Web of Science ®Google Scholar
• Schageman J, Zeringer E, Li M, et al. The complete exosome workflow solution: from isolation to characterization of RNA cargo. Biomed Res Int. 2013;2013;253957.
   PubMed Web of Science ®Google Scholar
• He M, Crow J, Roth M, et al. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip. 2014;14:3773.
   PubMed Web of Science ®Google Scholar
• Alexander VV, Emily Zeringer M, Li, et al. Methods for the extraction and RNA profiling of exosomes. World J Methodol. 2013;3:11–18.
   PubMedGoogle Scholar
• Lässer C, Eldh M, Lötvall J. Isolation and characterization of RNA-containing exosomes. J Vis Exp. 2012;59:1–6.
   Google Scholar
• Rupert DL, Lässer M, Eldh C, et al. Determination of exosome concentration in solution using surface plasmon resonance spectroscopy. Anal Chem. 2014;86:5929–5936.
   PubMed Web of Science ®Google Scholar
• Kanwar SS, Dunlay CJ, Simeone DM, et al. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014;14:1891–1900.
   PubMed Web of Science ®Google Scholar
• Liu KJ, Brock MV, Shih IM, et al. Decoding circulating nucleic acids in human serum using microfluidic single molecule spectroscopy. J Am Chem Soc. 2010;132:5793–5798.
   PubMed Web of Science ®Google Scholar
• García-Olmo DC, Ruiz-Piqueras R, García-Olmo D. Circulating nucleic acids in plasma and serum (CNAPS) and its relation to stem cells and cancer metastasis: state of the issue. Histol Histopathol. 2004;19:575–583.
   PubMed Web of Science ®Google Scholar
• Anker P, Mulcahy H, Stroun M. Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: time for large-scale clinical studies? Int J Cancer. 2003;103:149–152.
   PubMed Web of Science ®Google Scholar
• Gahan PB, Swaminathan R. Circulating nucleic acids in plasma and serum: recent developments. Ann N Y Acad Sci. 2008;1137:1–6.
   PubMed Web of Science ®Google Scholar
• Ma M, Zhu H, Zhang C, et al. Liquid biopsy’-ctDNA detection with great potential and challenges. Ann Transl Med. 2015;3:235.
   PubMed Web of Science ®Google Scholar
• Liang B, Peng P, Chen S, et al. Characterization and proteomic analysis of ovarian cancer-derived exosomes. J Proteomics. 2013;80:171–182.
   PubMed Web of Science ®Google Scholar
• Grasso L, Wyss R, Weidenauer L, et al. Molecular screening of cancer-derived exosomes by surface plasmon resonance spectroscopy. Anal Bioanal Chem. 2015;407:5425–5432.
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu HJ, Fine D, et al. Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip. 2013;13:2879–2882.
   Google Scholar
• Aro K, Wei F, Wong DT, et al. Saliva liquid biopsy for point-of-care applications. Front Public Health. 2017;5:77.
   PubMed Web of Science ®Google Scholar
• De Mattos-Arruda L, Mayor R, Ng CKY, et al. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun. 2015;6:8839.
   PubMed Web of Science ®Google Scholar
• Ward DG, Bryan RT. Liquid biopsies for bladder cancer. Transl Androl Urol. 2017;6:331–335.
   PubMed Web of Science ®Google Scholar
• Oliveira-Rodríguez M, López-Cobo S, Reyburn HT, et al. Development of a rapid lateral flow immunoassay test for detection of exosomes previously enriched from cell culture medium and body fluids. J Extracell Vesicles. 2016;5:1–10.
   Web of Science ®Google Scholar
• Di Meo A, Bartlett J, Cheng Y, et al. Liquid biopsy: a step forward towards precision medicine in urologic malignancies. Mol Cancer. 2017;16:80.
   PubMed Web of Science ®Google Scholar
• Mohamadi RM, Ivanov I, Stojcic J, et al. Sample-to-answer isolation and mRNA profiling of circulating tumor cells. Anal Chem. 2015;87:6258–6264.
   PubMed Web of Science ®Google Scholar
• Tan SJ, Yobas L, Lee GYH, et al. Microdevice for the isolation and enumeration of cancer cells from blood. Biomed Microdevices. 2009;11:883–892.
   PubMed Web of Science ®Google Scholar
• Wu CH, Huang YY, Chen P, et al. Versatile immunomagnetic nanocarrier platform for capturing cancer cells. ACS Nano. 2013;7:8816–8823.
   PubMed Web of Science ®Google Scholar
• Lim LS, Hu M, Huang MC, et al. Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells. Lab Chip. 2012;12:4388.
   PubMed Web of Science ®Google Scholar
• Lennon NJ, Adalsteinsson VA, Gabriel SB. Technological considerations for genome-guided diagnosis and management of cancer. Genome Med. 2016;8:112.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzás EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:1–25.
   Google Scholar
• Simpson RJ, Greening DW. Serum/plasma proteomics. New York (NY): Springer; 2011.
   Google Scholar
• Kaczor-Urbanowicz KE, Mart Carreras-Presas C, Kaczor T, et al. Emerging technologies for salivaomics in cancer detection. J Cell Mol Med. 2017;21:640–647.
   PubMed Web of Science ®Google Scholar
• Laxman B, Morris DS, Yu J, et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. Cancer Res. 2008;68:645–649.
   PubMed Web of Science ®Google Scholar
• Lianidou ES, Markou A. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges. Clin Chem. 2011;57:1242–1255.
   PubMed Web of Science ®Google Scholar
• Alix-Panabières C, Pantel K. Technologies for detection of circulating tumor cells: facts and vision. Lab Chip. 2014;14:57–62.
   PubMed Web of Science ®Google Scholar
• Bidard FC, Mathiot C, Delaloge S, et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann Oncol. 2010;21:729–733.
   PubMed Web of Science ®Google Scholar
• Yu M, Stott S, Toner M, et al. Circulating tumor cells: approaches to isolation and characterization. J Cell Biol. 2011;192:373–382.
   PubMed Web of Science ®Google Scholar
• Earhart CM, Hughes CE, Gaster RS, et al. Isolation and mutational analysis of circulating tumor cells from lung cancer patients with magnetic sifters and biochips. Lab Chip. 2014;14:78–88.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang Y, Sun S, et al. Single-cell codetection of metabolic activity, intracellular functional proteins, and genetic mutations from rare circulating tumor cells. Anal Chem. 2015;87:9761–9768.
   PubMed Web of Science ®Google Scholar
• Chen P, Huang YY, Hoshino K, et al. Microscale magnetic field modulation for enhanced capture and distribution of rare circulating tumor cells. Sci Rep. 2015;5:8745.
   PubMed Web of Science ®Google Scholar
• Park S, Wong DJ, Ooi CC, et al. Molecular profiling of single circulating tumor cells from lung cancer patients. Proc Natl Acad Sci USA. 2016;113:E8379–E8386.
   PubMed Web of Science ®Google Scholar
• Ghazani AA, Pectasides M, Sharma A, et al. Molecular characterization of scant lung tumor cells using iron-oxide nanoparticles and micro-nuclear magnetic resonance. Nanomedicine. 2014;10:661–668.
   PubMed Web of Science ®Google Scholar
• Sequist LV, Nagrath S, Toner M, et al. The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. J Thorac Oncol. 2009;4:281–283.
   PubMed Web of Science ®Google Scholar
• Zhao L, Lu YT, Li F, et al. High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Adv Mater. 2013;25:2897–2902.
   PubMed Web of Science ®Google Scholar
• Pratt E, Stepansky D, Hicks AJ, et al. Single-cell copy number analysis of prostate cancer cells captured with geometrically enhanced differential immunocapture microdevices. Anal Chem. 2014;86:11013–11017.
   Google Scholar
• Khoo BL, Warkiani ME, Tan DSW, et al. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. PLoS One. 2014;9:1–7.
   Web of Science ®Google Scholar
• Khamenehfar A, Beischlag TV, Russell PJ, et al. Label-free isolation of a prostate cancer cell among blood cells and the single-cell measurement of drug accumulation using an integrated microfluidic chip. Biomicrofluidics. 2015;9:1–18.
   Web of Science ®Google Scholar
• Patroni A, Denis JA, Guillerm E, et al. Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery. Mol Oncol. 2016;10:1221–1231.
   PubMed Web of Science ®Google Scholar
• Yu X, Wang B, Zhang N, et al. Capture and release of cancer cells by combining on-chip purification and off-chip enzymatic treatment. ACS Appl Mater Interfaces. 2015;7:24001–24007.
   PubMed Web of Science ®Google Scholar
• Hvichia GE, Parveen Z, Wagner C, et al. A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells. Int J Cancer. 2016;138:2894–2904.
   PubMed Web of Science ®Google Scholar
• Li P, Mao Z, Peng Z, et al. Acoustic separation of circulating tumor cells. Proc Natl Acad Sci USA. 2015;112:4970–4975.
   Google Scholar
• Sollier E, Go DE, Che J, et al. Size-selective collection of circulating tumor cells using Vortex technology. Lab Chip. 2014;14:63–77.
   PubMed Web of Science ®Google Scholar
• Wang C, Ye M, Cheng L, et al. Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes. Biomaterials. 2015;54:55–62.
   PubMed Web of Science ®Google Scholar
• Weian Shenga TJ, Ogunwobib OO, Chenc T, et al. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip weian. Lab Chip. 2014;14:89–98.
   PubMed Web of Science ®Google Scholar
• Gorges TM, Penkalla N, Schalk T, et al. Enumeration and molecular characterization of tumor cells in lung cancer patients using a novel in vivo device for capturing circulating tumor cells. Clin Cancer Res. 2016;22:2197–2206.
   PubMed Web of Science ®Google Scholar
• Karabacak NM, Spuhler PS, Fachin F, et al. Microfluidic, marker-free isolation of circulating tumor cells from blood samples. Nat Protoc. 2014;9:694–710.
   PubMed Web of Science ®Google Scholar
• Ferreira MM, Ramani VC, Jeffrey SS. Circulating tumor cell technologies. Mol Oncol. 2016;10:374–394.
   PubMed Web of Science ®Google Scholar
• Barriere G, Fici P, Gallerani G, et al. Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations. Ann Transl Med. 2014;2:109.
   PubMedGoogle Scholar
• Deng Y, Zhang Y, Sun S, et al. An integrated microfluidic chip system for single-cell secretion profiling of rare circulating tumor cells. Sci Rep. 2014;4:7499.
   PubMed Web of Science ®Google Scholar
• Hristozova T, Konschak R, Budach V, et al. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers. Cytometry A. 2012;81:489–495.
   PubMedGoogle Scholar
• Hoshino K, Huang YY, Lane N, et al. Microchip-based immunomagnetic detection of circulating tumor cells. Lab Chip. 2011;11:3449.
   PubMed Web of Science ®Google Scholar
• Wu J, Wei X, Gan J, et al. Multifunctional magnetic particles for combined circulating tumor cells isolation and cellular metabolism detection. Adv Funct Mater. 2016;26:4016–4025.
   PubMed Web of Science ®Google Scholar
• Tan SJ, Lakshmi RL, Chen P, et al. Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron. 2010;26:1701–1705.
   PubMed Web of Science ®Google Scholar
• Ozkumur E, Shah AM, Ciciliano JC, et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med. 2013;5:179ra47–179ra47.
   Web of Science ®Google Scholar
• Valadi H, Ekstrom K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659.
   PubMed Web of Science ®Google Scholar
• Skog J, Wurdinger T, van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–1476.
   PubMed Web of Science ®Google Scholar
• Staals RH, Pruijn GJ. The human exosome and disease. In: Jensen T H, editor. RNA Exosome. New York (NY): Springer; 2010. p. 132–142.
   Google Scholar
• Zeng S, Zhao Y, Yang Z, et al. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip. 2016;16:489–496.
   Google Scholar
• Shao H, Chung J, Lee K, et al. Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun. 2015;6:6999.
   PubMed Web of Science ®Google Scholar
• Yoshioka Y, Kosaka N, Konishi Y, et al. Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen. Nat Comms. 2014;5:1–8.
   Web of Science ®Google Scholar
• Vaidyanathan R, Naghibosadat M, Rauf S, et al. Detecting exosomes specifically: a multiplexed device based on alternating current electrohydrodynamic induced nanoshearing. Anal Chem. 2014;86:11125–11132.
   Google Scholar
• Akagi T, Kato K, Kobayashi M, et al. On-chip immunoelectrophoresis of extracellular vesicles released from human breast cancer cells. PLoS One. 2015;10:1–13.
   Web of Science ®Google Scholar
• Gagni P, Cretich M, Benussi L, et al. Combined mass quantitation and phenotyping of intact extracellular vesicles by a microarray platform. Anal Chim Acta. 2016;902:160–167.
   PubMed Web of Science ®Google Scholar
• Kim SC, Dogra N, Wunsch BH, et al. On-chip liquid biopsy: progress in isolation of exosomes for early diagnosis of cancer. Biophys J. 2017;112:461a.
   Web of Science ®Google Scholar
• Yang Z, Zeng YY, He M, et al. A microfluidic ExoSearch chip for multiplexed exosome detection towards blood-based ovarian cancer diagnosis. Lab Chip. 2015;16:489–496.
   Web of Science ®Google Scholar
• Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11:426–437.
   PubMed Web of Science ®Google Scholar
• Jiang P, Lo YMD. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 2016;32:360–371.
   Web of Science ®Google Scholar
• Mouliere F, El Messaoudi S, Gongora C, et al. Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl Oncol. 2013;6:319–328.
   PubMed Web of Science ®Google Scholar
• Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev. 1999;18:65–73.
   PubMed Web of Science ®Google Scholar
• Bardelli A, Pantel K. Liquid biopsies, what we do not know (yet). Cancer Cell. 2017;31:172–179.
   PubMed Web of Science ®Google Scholar
• Wei F, Lin CC, Joon A, et al. Noninvasive saliva-based EGFR gene mutation detection in patients with lung cancer. Am J Respir Crit Care Med. 2014;190:1117–1126.
   PubMed Web of Science ®Google Scholar
• Egatz-Gomez A, Wang C, Klacsmann F, et al. Future microfluidic and nanofluidic modular platforms for nucleic acid liquid biopsy in precision medicine. Biomicrofluidics. 2016;10:3.
   Web of Science ®Google Scholar
• Sefrioui D ,Sarafan-Vasseur N, Beaussire L, et al. Clinical value of chip-based digital-PCR platform for the detection of circulating DNA in metastatic colorectal cancer. Dig Liver Dis. 2015;47:884–890.
   PubMedGoogle Scholar
• Zhang Y, Bailey V, Puleo CM, et al. DNA methylation analysis on a droplet-in-oil PCR array. Lab Chip. 2009;9:1059–1064.
   PubMed Web of Science ®Google Scholar
• Wu Z, Bai Y, Cheng Z, et al. Absolute quantification of DNA methylation using microfluidic chip-based digital PCR. Biosens Bioelectron. 2017;96:339–344.
   PubMed Web of Science ®Google Scholar
• Taly V, Pekin D, Benhaim L, et al. Multiplex picodroplet digital PCR to detect KRAS mutations in circulating DNA from the plasma of colorectal cancer patients. Clin Chem. 2013;59:1722–1731.
   PubMed Web of Science ®Google Scholar
• López SO, García-Olmo DC, García-Arranz M, et al. KRAS G12V mutation detection by droplet digital PCR in circulating cell-free DNA of colorectal cancer patients. Int J Mol Sci. 2016;17:1–9.
   Web of Science ®Google Scholar
• Li Z, Liu Y, Wei Q, et al. Picoliter well array chip-based digital recombinase polymerase amplification for absolute quantification of nucleic acids. PLoS One. 2016;11:1–15.
   Web of Science ®Google Scholar
• Han L, Liu P, Petrenko VA, et al. A label-free electrochemical impedance cytosensor based on specific peptide-fused phage selected from landscape phage library. Sci Rep. 2016;6:22199.
   PubMed Web of Science ®Google Scholar
• Labib M, Khan N, Ghobadloo SM, et al. Three-mode electrochemical sensing of ultralow MicroRNA levels. J Am Chem Soc. 2013;135:3027–3038.
   PubMed Web of Science ®Google Scholar
• Cai H, Stott MA, Ozcelik D, et al. On-chip wavelength multiplexed detection of cancer DNA biomarkers in blood. Biomicrofluidics. 2016;10:6.
   Web of Science ®Google Scholar
• Joshi GK, Deitz-mcelyea S, Liyanage K, et al. Short noncoding RNA sensing at attomolar concentrations allows for quantitative and highly specific assay of microRNA-10b in biological fluids and circulating exosomes. ACS Nano. 2015;9:11075–11089.
   Google Scholar
• Dias TM, Cardoso FA, Martins SAM, et al. Implementing a strategy for on-chip detection of cell-free DNA fragments using GMR sensors: a translational application in cancer diagnostics using ALU elements. Anal Methods. 2016;8:119–128.
   Web of Science ®Google Scholar
• Rahman MM, Elaissari A. Nucleic acid sample preparation for in vitro molecular diagnosis: from conventional techniques to biotechnology. Drug Discov Today. 2012;17:1199–1207.
   PubMed Web of Science ®Google Scholar